WO2001093829A3 - Powder compositions - Google Patents
Powder compositions Download PDFInfo
- Publication number
- WO2001093829A3 WO2001093829A3 PCT/US2001/018494 US0118494W WO0193829A3 WO 2001093829 A3 WO2001093829 A3 WO 2001093829A3 US 0118494 W US0118494 W US 0118494W WO 0193829 A3 WO0193829 A3 WO 0193829A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drying
- powder
- compositions
- prepared
- spray
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA02012039A MXPA02012039A (en) | 2000-06-08 | 2001-06-08 | Powder compositions. |
JP2002501402A JP2003535119A (en) | 2000-06-08 | 2001-06-08 | Powder composition |
NZ523103A NZ523103A (en) | 2000-06-08 | 2001-06-08 | Salt adjuvant-containing vaccine freeze-dried compositions in a powder form for transdermal delivery from a needless syringe |
CA002412197A CA2412197A1 (en) | 2000-06-08 | 2001-06-08 | Powder compositions |
EP01942075A EP1289494A2 (en) | 2000-06-08 | 2001-06-08 | Powder compositions |
BR0111494-8A BR0111494A (en) | 2000-06-08 | 2001-06-08 | Gel-forming free-flowing powder suitable for use as a vaccine, process for preparing it, dosage container for a needleless syringe, needleless syringe, vaccine composition, method for vaccinating an individual, suitable powder for use as a vaccine. a vaccine, and process for preparing it |
AU2001275371A AU2001275371B9 (en) | 2000-06-08 | 2001-06-08 | Powder compositions |
IL15324101A IL153241A0 (en) | 2000-06-08 | 2001-06-08 | Powder compositions |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21058100P | 2000-06-08 | 2000-06-08 | |
US59077700A | 2000-06-08 | 2000-06-08 | |
US09/590,777 | 2000-06-08 | ||
US60/210,581 | 2000-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001093829A2 WO2001093829A2 (en) | 2001-12-13 |
WO2001093829A3 true WO2001093829A3 (en) | 2002-06-13 |
Family
ID=26905296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/018494 WO2001093829A2 (en) | 2000-06-08 | 2001-06-08 | Powder compositions |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1289494A2 (en) |
JP (1) | JP2003535119A (en) |
KR (1) | KR20030020294A (en) |
CN (1) | CN1438874A (en) |
AU (1) | AU2001275371B9 (en) |
BR (1) | BR0111494A (en) |
CA (1) | CA2412197A1 (en) |
IL (1) | IL153241A0 (en) |
MX (1) | MXPA02012039A (en) |
NZ (2) | NZ552576A (en) |
WO (1) | WO2001093829A2 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7229645B2 (en) | 2001-06-08 | 2007-06-12 | Powderject Research Limited | Spray freeze-dried compositions |
CN1607941A (en) * | 2001-11-19 | 2005-04-20 | 贝克顿迪肯森公司 | Pharmaceutical compositions in particulate form |
US7923029B2 (en) | 2002-04-11 | 2011-04-12 | Medimmune Llc | Spray freeze dry of compositions for pulmonary administration |
DE10339197A1 (en) * | 2003-08-22 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Spray-dried amorphous powder with low residual moisture and good storage stability |
AR050959A1 (en) * | 2004-09-28 | 2006-12-06 | Alza Corp | STABILIZATION OF IMMUNOLOGICALLY ACTIVE AGENTS ASSISTED WITH STUDENTS |
CN101242948B (en) * | 2005-06-27 | 2012-06-13 | 应用薄膜股份有限公司 | Aluminum phosphate based microspheres |
CA2624503A1 (en) | 2005-10-04 | 2007-04-12 | Alk-Abello A/S | Solid vaccine formulation |
US20090035326A1 (en) * | 2005-11-01 | 2009-02-05 | Novartis Ag | Compositions with antigens adsorbed to calcium phosphate |
JP2010502747A (en) * | 2006-09-08 | 2010-01-28 | ベクトン・ディキンソン・アンド・カンパニー | A stable powder formulation of alum-adsorbed vaccine |
EP2077821B1 (en) | 2006-10-12 | 2019-08-14 | The University Of Queensland | Compositions and methods for modulating immune responses |
US8444991B2 (en) | 2007-03-22 | 2013-05-21 | The Regents Of The University Of Colorado, A Body Corporate | Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
KR101540920B1 (en) * | 2007-07-26 | 2015-08-03 | 사노피 파스퇴르 리미티드 | Antigen-adjuvant compositions and methods |
AU2009221180B2 (en) * | 2008-03-05 | 2014-02-13 | Sanofi Pasteur | Process for stabilizing an adjuvant containing vaccine composition |
AU2009299615B2 (en) | 2008-10-02 | 2015-07-16 | Pharmathene Inc. | Anthrax vaccine formulation and uses thereof |
CN102892427A (en) | 2010-03-31 | 2013-01-23 | 稳定性科技有限公司 | Excipients for stabilising viral particles, polypeptides or biological material |
HUE042330T2 (en) * | 2010-03-31 | 2019-06-28 | Stabilitech Biopharma Ltd | Method for preserving alum adjuvants and alum-adjuvanted vaccines |
ES2543795T3 (en) | 2010-03-31 | 2015-08-21 | Stabilitech Ltd. | Stabilization of viral particles |
JP2013545453A (en) | 2010-11-01 | 2013-12-26 | ユニバーシティ・オブ・テクノロジー、シドニー | Immunomodulators and their use |
EA201390810A1 (en) | 2010-12-02 | 2013-09-30 | Онколитикс Байотек Инк. | LIQUID VIRAL COMPOSITIONS |
KR102023207B1 (en) | 2010-12-02 | 2019-11-25 | 온콜리틱스 바이오테크 인코포레이티드 | Lyophilized viral formulations |
CN102133396B (en) * | 2011-03-16 | 2013-10-16 | 中国人民解放军第三〇二医院 | Vaccine injection and preparation method thereof |
GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
AU2013228096B2 (en) * | 2012-03-05 | 2017-07-13 | Intravacc B.V. | Methods and compositions for stabilizing dried biological materials |
KR101441539B1 (en) * | 2013-04-01 | 2014-09-18 | 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 | Adhesive compositions having improved hygroscopicity and preparation methods thereof |
CN103641886B (en) * | 2013-11-26 | 2015-07-29 | 精晶药业股份有限公司 | A kind of process for purification of glutamine dipeptide |
GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0065905A1 (en) * | 1981-05-13 | 1982-12-01 | Institut Pasteur | Stabilizing agents for live viruses for the preparation of vaccines, and stabilized vaccines containing these stabilizing agents |
GB2135190A (en) * | 1983-02-22 | 1984-08-30 | Human Oltoanyagtermelo | Lyophilized adsorbed polyvalent vaccines |
EP0130619A2 (en) * | 1983-07-05 | 1985-01-09 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Hepatitis B vaccine and method for its preparation |
WO1994015636A1 (en) * | 1993-01-08 | 1994-07-21 | Csl Limited | Vaccine preparations |
US5630796A (en) * | 1993-04-08 | 1997-05-20 | Oxford Biosciences Limited | Method of delivering powder transdermally with needless injector |
RU2096042C1 (en) * | 1996-11-06 | 1997-11-20 | Виктор Иванович Ситьков | Method of preparing multipartial vaccine for leptospirosis control in animals |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994015363A1 (en) * | 1992-12-28 | 1994-07-07 | Yu Shih Chiang | Non-volatile semiconductor memory cell |
US5902565A (en) * | 1993-12-24 | 1999-05-11 | Csl Limited | Spray dried vaccine preparation comprising aluminium adsorbed immunogens |
CN1285753A (en) * | 1997-12-02 | 2001-02-28 | 鲍德杰克特疫苗公司 | Transdermal delivery of particulate vaccine compositions |
-
2001
- 2001-06-08 CN CN01811745A patent/CN1438874A/en active Pending
- 2001-06-08 JP JP2002501402A patent/JP2003535119A/en active Pending
- 2001-06-08 NZ NZ552576A patent/NZ552576A/en unknown
- 2001-06-08 WO PCT/US2001/018494 patent/WO2001093829A2/en active IP Right Grant
- 2001-06-08 KR KR1020027016801A patent/KR20030020294A/en not_active Application Discontinuation
- 2001-06-08 NZ NZ523103A patent/NZ523103A/en unknown
- 2001-06-08 AU AU2001275371A patent/AU2001275371B9/en not_active Ceased
- 2001-06-08 BR BR0111494-8A patent/BR0111494A/en not_active Application Discontinuation
- 2001-06-08 IL IL15324101A patent/IL153241A0/en unknown
- 2001-06-08 EP EP01942075A patent/EP1289494A2/en not_active Withdrawn
- 2001-06-08 MX MXPA02012039A patent/MXPA02012039A/en active IP Right Grant
- 2001-06-08 CA CA002412197A patent/CA2412197A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0065905A1 (en) * | 1981-05-13 | 1982-12-01 | Institut Pasteur | Stabilizing agents for live viruses for the preparation of vaccines, and stabilized vaccines containing these stabilizing agents |
GB2135190A (en) * | 1983-02-22 | 1984-08-30 | Human Oltoanyagtermelo | Lyophilized adsorbed polyvalent vaccines |
EP0130619A2 (en) * | 1983-07-05 | 1985-01-09 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Hepatitis B vaccine and method for its preparation |
WO1994015636A1 (en) * | 1993-01-08 | 1994-07-21 | Csl Limited | Vaccine preparations |
US5630796A (en) * | 1993-04-08 | 1997-05-20 | Oxford Biosciences Limited | Method of delivering powder transdermally with needless injector |
RU2096042C1 (en) * | 1996-11-06 | 1997-11-20 | Виктор Иванович Ситьков | Method of preparing multipartial vaccine for leptospirosis control in animals |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Section Ch Week 199828, Derwent World Patents Index; Class B04, AN 1998-320414, XP002195515 * |
Also Published As
Publication number | Publication date |
---|---|
KR20030020294A (en) | 2003-03-08 |
AU7537101A (en) | 2001-12-17 |
CN1438874A (en) | 2003-08-27 |
IL153241A0 (en) | 2003-07-06 |
JP2003535119A (en) | 2003-11-25 |
NZ523103A (en) | 2005-08-26 |
MXPA02012039A (en) | 2003-06-06 |
CA2412197A1 (en) | 2001-12-13 |
BR0111494A (en) | 2004-01-13 |
EP1289494A2 (en) | 2003-03-12 |
WO2001093829A2 (en) | 2001-12-13 |
AU2001275371B2 (en) | 2006-12-21 |
AU2001275371B9 (en) | 2007-06-07 |
NZ552576A (en) | 2008-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001093829A3 (en) | Powder compositions | |
WO2001060402A3 (en) | Proteosome influenza vaccine | |
GB0118249D0 (en) | Histidine vaccines | |
KR101960102B1 (en) | Methods and compositions for intranasal delivery | |
WO2000023105A3 (en) | Adjuvant systems and vaccines | |
JP2000502672A (en) | Live vaccine stabilizer | |
RU2004122632A (en) | LYOPHILIZED DRUG CONTAINING ANTIBODIES AGAINST EGF RECEPTOR | |
CN102892409B (en) | For preserving the method for Alum adjuvant and aluminum salt-adjuvanted vaccine | |
AU2008225501B2 (en) | Lyophilized preparation comprising influenza vaccine, and method for preparation thereof | |
WO2004000351A8 (en) | Packaged virus-like particles for use as adjuvants: method of preparation and use | |
WO2002028422A3 (en) | Split enveloped virus preparation for intranasal delivery | |
JP2004505024A5 (en) | ||
CA2428870A1 (en) | Freeze-dried pantoprazole preparation and pantoprazole injection | |
WO2008079464A8 (en) | Stable powder formulations of alum-adsorbed vaccines | |
CA2282779A1 (en) | Formulation comprising an antigen, an adjuvant and an amino acid for use in immunization. | |
IL166526A0 (en) | Antigenic compositions | |
CA2169297A1 (en) | Protein- or peptide-cochleate vaccines and methods of immunizing using the same | |
JP2004505992A5 (en) | ||
KR20110080167A (en) | Preservation mixture and use thereof | |
WO2003005952A3 (en) | Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres | |
CN1050987A (en) | Be used for oral stable immunogenic composition | |
JP2017509713A5 (en) | ||
WO2023235660A3 (en) | Flavivirus immunogens and vaccine compositions and methods of using the same | |
EA200200294A1 (en) | SPHERICAL AGLOMERATES OF THYLTROMYCINE, METHOD FOR THEIR PRODUCTION AND THEIR APPLICATION FOR PREPARATION OF MEDICINAL FORMS | |
MXPA05010629A (en) | Taste-masking vehicle for coated oxazolidinone particles. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 153241 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/012039 Country of ref document: MX Ref document number: IN/PCT/2002/2012/CHE Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2002 501402 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020027016801 Country of ref document: KR Ref document number: 2412197 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 523103 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001275371 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018117457 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001942075 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027016801 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2001942075 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 523103 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 523103 Country of ref document: NZ |